Relmada Therapeutics Inc at Jefferies Healthcare Conference Transcript
Okay. We're going to get started with our next session. Hi, everyone. I'm Andrew Tsai, senior biotech analyst here at Jefferies. Thanks for tuning in, and it's my pleasure to have the Relmada team joining me today. I have to the left of me, Sergio Traversa, CEO; and to the left of him, Cedric O'Gorman, CMO. Welcome both of you.
' -
Thank you.
So maybe Sergio, Cedric, for those in the audience who are less familiar with the Relmada story, could you possibly give us an overview about your company, what you're trying to achieve, what stage of development you're in and the next set of catalysts we can expect over the coming months?
Okay. Well, first, Andrew, thank you very much for inviting us at the Jefferies conference. And welcome, everyone interested. And thanks for the
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
